WASHINGTON (GenomeWeb News) – Small studies, sometimes containing a single patient, can be applied to unravel the biological mechanisms behind cancer drug response as well as identify possible drug treatments for a specific cancer type, according to researchers.

While such small studies may be dismissed by some as anecdotes, panelists at an afternoon session yesterday at the American Association for Cancer Research annual meeting here argued that such studies can be used to resurrect abandoned drugs and to reveal known drugs to which a tumor may be susceptible.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Sep
17
Sponsored by
SeraCare

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.